A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2

Published:2020-11-03 Issue:1 Volume:13 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Simonis Alexander¹²,Theobald Sebastian J¹²,Fätkenheuer Gerd¹,Rybniker Jan¹²³,Malin Jakob J¹²^ORCID

Affiliation:

1. Department I of Internal Medicine Division of Infectious Diseases University of Cologne Cologne Germany

2. Faculty of Medicine Center for Molecular Medicine Cologne (CMMC) University of Cologne Cologne Germany

3. German Center for Infection Research (DZIF) Partner Site Bonn‐Cologne Cologne Germany

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.202013105

Reference136 articles.

1. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

2. Remdesivir use in patients with coronavirus COVID‐19 disease: a systematic review and meta‐analysis;Alexander PE;medRxiv,2020

3. Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS Drugs

4. Membrane-Anchored Serine Proteases in Health and Disease

5. Isolation, Sequence, Infectivity, and Replication Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial intelligence for drug repurposing against infectious diseases;Artificial Intelligence Chemistry;2024-12

2. Further preclinical characterization of molnupiravir against SARS-CoV-2: Antiviral activity determinants and viral genome alteration patterns;Heliyon;2024-05

3. Developing nucleoside tailoring strategies against SARS-CoV-2 via ribonuclease targeting chimera;Science Advances;2024-04-12

4. Syringa reticulata potently inhibits the activity of SARS-CoV-2 3CL protease;Biochemistry and Biophysics Reports;2024-03

5. Clinical development of antivirals against SARS-CoV-2 and its variants;Current Research in Microbial Sciences;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3